TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from VSee Health ( (VSEE) ).
On November 17, 2025, VSee Health, Inc. announced the issuance of a Convertible Promissory Note and plans to issue shares of Common Stock upon conversion of the Note. This move is made under the exemption from registration provided by the Securities Act of 1933 and Regulation D. The agreement, dated October 29, 2025, marks a significant financial maneuver for VSee Health, potentially impacting its market operations and investor relations.
The most recent analyst rating on (VSEE) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on VSee Health stock, see the VSEE Stock Forecast page.
Spark’s Take on VSEE Stock
According to Spark, TipRanks’ AI Analyst, VSEE is a Neutral.
VSee Health’s overall stock score is primarily impacted by its weak financial performance, characterized by negative profit margins and a precarious balance sheet. Technical analysis provides some hope for stabilization, but the bearish trend remains a concern. The valuation is unattractive due to the negative P/E ratio and lack of dividend yield. The absence of earnings call data and corporate events limits additional insights.
To see Spark’s full report on VSEE stock, click here.
More about VSee Health
Average Trading Volume: 12,966,155
Technical Sentiment Signal: Sell
Current Market Cap: $12.63M
Find detailed analytics on VSEE stock on TipRanks’ Stock Analysis page.